Bio Rad Laboratories Inc当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名149/208位。机构持股占比非常低,近一个月,市场表现一般,但基本面评分较高。
Bio Rad Laboratories Inc评分
相关信息
行业排名
149 / 208
全市场排名
402 / 4582
所属行业
医疗设备与耗材
压力支撑
由于公司未披露,未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
0
位分析师
--
评级
0.000
目标均价
0.00%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议
Bio Rad Laboratories Inc亮点
亮点风险
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
公司代码BIOb
公司Bio Rad Laboratories Inc
CEOSchwartz (Norman D)
网址https://www.bio-rad.com/
常见问题
Bio Rad Laboratories Inc(BIOb)的当前股价是多少?
Bio Rad Laboratories Inc(BIOb)的当前股价是 300.500。
Bio Rad Laboratories Inc的股票代码是什么?
Bio Rad Laboratories Inc的股票代码是BIOb。
Bio Rad Laboratories Inc股票的52周最高点是多少?
Bio Rad Laboratories Inc股票的52周最高点是359.220。
Bio Rad Laboratories Inc股票的52周最低点是多少?
Bio Rad Laboratories Inc股票的52周最低点是225.290。
Bio Rad Laboratories Inc的市值是多少?
Bio Rad Laboratories Inc的市值是8.11B。
Bio Rad Laboratories Inc的净利润是多少?
Bio Rad Laboratories Inc的净利润为-1.84B。
现在Bio Rad Laboratories Inc(BIOb)的股票是买入、持有还是卖出?
根据分析师评级,Bio Rad Laboratories Inc(BIOb)的总体评级为--,目标价格为--。
Bio Rad Laboratories Inc(BIOb)股票的每股收益(EPS TTM)是多少
Bio Rad Laboratories Inc(BIOb)股票的每股收益(EPS TTM)是-24.014。